Sigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-K : vimarsana.com

SAN DIEGO, CA, Feb. 21, 2024 -- via NewMediaWire – Sigyn Therapeutics, Inc. , a development-stage medical technology company, announced today the filing of its Form 10-K annual report with the...

Related Keywords

United States , California , San Diego , Jim Joyce , Drug Administration , Company Annual Report On Form , Securities Exchange , Sigyn Therapeutics Inc , Exchange Commission , Globenewswire Inc , States Securities , Investigational Device Exemption , States Food , Sigyn Therapeutics , Securities Act , Securities Exchange Act , Sigyn Therapy , Annual Report , Markets ,